Intarcia Therapeutics Garners $75,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b1aebf2-476c-46d6-83f3-df1e3595401b - Date
5/6/2016 - Company Name
Intarcia Therapeutics - Mailing Address
155 Seaport Boulevard 11th Floor Boston, MA 02210 USA - Company Description
Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories. - Website
http://www.intarcia.com - Transaction Type
Debt - Transaction Amount
$75,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The company will use the proceeds to ramp up manufacturing to build inventory for a prospective late 2017 commercial launch. - M&A Terms
- Venture Investor
Silicon Valley Bank - Venture Investor
MidCap Financial
